51 results
8-K/A
EX-99.1
GMDAQ
Gamida Cell Ltd
5 Apr 24
Other Events
5:16pm
shares at an exercise price of $1.35 per share. The warrants liability was valued using a Black Scholes Option Pricing Model, which is considered … to be a Level 3 fair value measurement. The Black Scholes model’s primary unobservable input utilized in determining the fair value of the warrants
DEFR14A
9jv0v
9 May 23
Revised proxy
5:25pm
8-K
EX-4.1
cbd fggdc
21 Apr 23
Gamida Cell Announces Launch of Public Offering of Securities
7:19am
424B5
j62qth9tnpox6 l3vujn
20 Apr 23
Prospectus supplement for primary offering
5:27pm
424B5
6a01ob7u7i pa6
19 Apr 23
Prospectus supplement for primary offering
6:46am
8-K
EX-99.1
wzfdc8
17 Apr 23
Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval
5:29pm
424B5
uwh41
29 Sep 22
Prospectus supplement for primary offering
4:08pm
424B5
yoae npz1
27 Sep 22
Prospectus supplement for primary offering
5:01pm